Inherited retinal diseases (IRDs) are a group of conditions that can cause vision loss due to retinal dysfunction. In recent years, the understanding of

Novartis is building on its front-of-eye therapies to address unmet patient needs with the acquisition of Kedalion Therapeutics and its AcuStream technology.

Accessible and equitable healthcare is at the heart of the Australian College of Optometry (ACO), which over the years has built a strong history

Multimodal imaging has enabled researchers from the National Eye Institute (NEI) in the United States to determine that retinal lesions from vitelliform macular dystrophy